Overview Request Sample Pages Request Customization Download PDF
You are viewing: New Zealand Gastrointestinal Stent Market analysis
Part of: Gastrointestinal Stent Market (Global)

The New Zealand Gastrointestinal Stent Market was valued at $2.47 Million in 2026 and projected to reach to $3.17 Million by 2031, representing a compound annual growth rate of 5.1%. New Zealand's gastrointestinal stent market is poised for steady growth driven by an aging population and increasing prevalence of esophageal, biliary, and colorectal conditions requiring intervention.

New Zealand Gastrointestinal Stent Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

New Zealand Gastrointestinal Stent Market Trends and Insights

  • New Zealand's healthcare infrastructure and aging population are driving demand for minimally invasive gastrointestinal interventions.
  • The market in New Zealand reflects broader Asia Pacific trends toward advanced endoscopic therapies, supported by increasing prevalence of esophageal, biliary, and colorectal conditions. New Zealand's gastrointestinal stent adoption is influenced by healthcare reimbursement policies, specialist availability, and patient access to tertiary care facilities.
  • New Zealand continues to integrate newer stent technologies, including fully covered metal stents and biodegradable options, into clinical practice.
  • The forecast period through 2031 indicates steady expansion as New Zealand's healthcare system prioritizes cost-effective, patient-centric treatment modalities for obstructive gastrointestinal pathologies..

Key Market Statistics

  • CAGR (2026-2031) 5.1% CAGR
  • Market Size, 2026 ~USD 2.47 Million
  • Forecast, 2031 ~USD 3.17 Million
  • Country New Zealand

New Zealand Gastrointestinal Stent Market Overview

Market Size & Growth :

New Zealand's gastrointestinal stent market is valued at USD 2.47 million in 2026, expanding to USD 3.17 million by 2031 at a CAGR of 5.1%, slightly below the global average of 5.7%.

Aging Population Driver :

New Zealand's rapidly aging demographic is increasing prevalence of gastrointestinal disorders, creating sustained demand for minimally invasive stent interventions across public and private healthcare sectors.

Healthcare Infrastructure :

Advanced healthcare infrastructure and high adoption of minimally invasive procedures in New Zealand support market growth, with strong integration of endoscopic technologies in major hospitals and specialist centers.

Regional Market Position :

New Zealand represents a niche but growing segment within the Asia Pacific gastrointestinal stent market, characterized by premium product adoption and high procedural standards aligned with developed healthcare systems.

New Zealand Gastrointestinal Stent Market Dynamics

  • The country's well-developed healthcare system and strong adoption of minimally invasive procedures support market expansion.
  • Healthcare providers are increasingly investing in advanced endoscopic equipment and training, enhancing procedural capabilities.
  • Reimbursement policies through the New Zealand public health system (DHBs) continue to support access to stent therapies, though budget constraints may moderate growth rates.
  • Market players are focusing on product innovation and partnerships with local healthcare institutions to strengthen market presence and improve patient outcomes in this specialized segment..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • New Zealand's gastrointestinal stent market is valued at USD 2.47 million in 2026 and will reach USD 3.17 million by 2031.
    • New Zealand's market is growing at a 5.1% CAGR, driven by aging demographics and increased endoscopic procedure adoption.
    • New Zealand's healthcare system is increasingly adopting advanced stent technologies including fully covered metal and biodegradable variants.
    • New Zealand's market growth is supported by improved reimbursement pathways and expanding access to tertiary care gastrointestinal services.

    Gastrointestinal Stent Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment BIODEGRADABLE STENTS (Type)
    Forecast Period 2026–2031
    Growth Rate CAGR of 5.7% from 2026 to 2031
    Largest Segment HOSPITALS & CLINICS (End User)
    Market Size Base Year (Billions) ~USD 0.62 (2026)
    Revenue Forecast (Billions) ~USD 0.82 (2031)
    Segments Covered Product, Type, Mechanism, Coverage, Application, End User

    New Zealand Gastrointestinal Stent Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Duodenal Stents
    • Esophageal Stents
    • Metal Stents
    • Pancreatic Stents
    • Plastic Stents

    By Type

    • Biliary Stents
    • Biodegradable Stents
    • Colonic Stents
    • Colorectal Cancer
    • Duodenal Stents
    • Esophageal Cancer
    • Esophageal Stents
    • Magnesium-Based Stents
    • Metal Stents
    • Nitinol Stents
    • Other Biodegradable Stents
    • Other Metal Stents
    • Pancreatic Cancer
    • Pancreatic Stents
    • Plastic Stents
    • Polymer-Based Stents
    • Stainless Steel Stents
    • Stomach Cancer

    By Mechanism

    • Balloon-Expandable Metal Stents (Bems)
    • Self-Expanding Metal Stents (Sems)

    By Coverage

    • Fully Covered Stents
    • Partially Covered Stents
    • Uncovered Stents

    By Application

    • Benign Strictures & Leaks
    • Biliary Disease
    • Biliary Diseases
    • Gastrointestinal Cancer
    • Other Applications

    By End User

    • Ambulatory Surgical Centers
    • Hospitals & Clinics
    • Specialty Endoscopy Centers/Gi Clinics

    Target Audience

    • Medical Device Manufacturers : Manufacturers need New Zealand market data to assess market entry feasibility, competitive positioning, and localization strategies for gastrointestinal stent products.
    • Healthcare Providers & Hospitals : Hospital administrators and gastroenterology departments require market insights to inform procurement decisions, budget planning, and technology adoption aligned with patient demand trends.
    • Distributors & Importers : Local and regional distributors need market intelligence to evaluate partnership opportunities, forecast demand, and optimize inventory management for New Zealand healthcare facilities.
    • Investment & Private Equity Firms : Investors evaluating healthcare sector opportunities in New Zealand require detailed market analysis to assess growth potential, competitive dynamics, and risk factors in the GI stent segment.
    • Healthcare Consultants & Analysts : Consultants advising healthcare organizations and government bodies need New Zealand-specific data to develop evidence-based recommendations on medical device policy and procurement strategies.

    Key Companies in the New Zealand Gastrointestinal Stent Market

    CompanyHQOwnershipStrongest segments
    ATS AUTOMATION TOOLING SYSTEMS INCCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation services and lifecycle support,Contract manufacturing and integration services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (coronary, structural heart, CRM, peripheral),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention),MedSurg – Urology and Pelvic Health,
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions (endoscopes, devices, services),Surgical Endoscopes & Integrated OR Solutions,Advanced Energy Devices,
    M.I. TECHMalaysiaPublic CompanyDie sorting and smart binning equipment,Test handling and vision inspection equipment,Laser bonding and precision bonding equipment,
    MICRO-TECH (NANJING) CO., LTD.ChinaPublic CompanyDigestive endoscopy – ESD and ERCP (therapeutic devices and accessories),Stents and dilation/biopsy systems (biliary, intestinal, esophageal),Hemostasis, EUS, and diagnostic accessories,
    MERIT MEDICAL SYSTEMSUnited StatesPublic CompanyCardiovascular access and intervention (micropuncture, sheaths, guidewires, angiography, hemostasis),Peripheral intervention and embolotherapy (angiography, drainage, delivery, embolic solutions),Oncology and spine (soft tissue biopsy, vertebral augmentation, RF ablation, bone biopsy),
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio,
    STERISIrelandPublic CompanyHealthcare sterilization, decontamination, and OR infrastructure,Applied Sterilization Technologies (outsourced sterilization services),Life sciences contamination control and processing,
    BDUnited StatesPublic CompanyMedical Essentials (IV access, syringes, needles, sharps, vascular care),Connected Care (infusion systems, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    Q3 MEDICAL GROUPIrelandPrivate CompanySpecialty procedures and interventions,Outpatient and ambulatory services,Diagnostics and imaging,
    BVMTunisiaPublic CompanyFire, miscellaneous accidents, and engineering,Marine, energy, and aviation (including pools),Agricultural and emerging risks,

    ATS AUTOMATION TOOLING SYSTEMS INC

    ATS Automation Tooling Systems Inc is a Canadian public company founded in 1978 that employs 7,000 people. The company specializes in automation and tooling systems.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees. The company operates in the medical device and healthcare sectors.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates across imaging, medical, and industrial technology sectors.

    M.I. TECH

    M.I. Tech is a Malaysian public company founded in 2007 with 594 employees. The company operates in the technology sector.

    MICRO-TECH (NANJING) CO., LTD.

    Micro-Tech (Nanjing) Co., Ltd. is a Chinese public company founded in 2000 with 2,433 employees. The company operates in the medical device industry.

    MERIT MEDICAL SYSTEMS

    Merit Medical Systems is a United States-based public company founded in 1987 with 7,500 employees. The company manufactures and distributes medical devices and supplies.

    MEDTRONIC

    Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

    STERIS

    STERIS is an Ireland-based public company founded in 1985. The company provides sterilization and contamination control solutions for healthcare and industrial markets.

    BD

    BD is a United States-based public company founded in 1897 with 72,000 employees. The company is a global medical technology company specializing in medical devices, diagnostics, and biosciences.

    Q3 MEDICAL GROUP

    Q3 Medical Group is an Ireland-based private company founded in 2013. The company operates in the medical device or healthcare sector.

    BVM

    BVM is a Tunisia-based public company founded in 1981 with 99 employees. The company operates in the medical or industrial sector.

    Reasons to Buy this Report

    • Localized Market Intelligence : Gain New Zealand-specific insights on market size, growth trajectories, and regional dynamics that differ from global averages, enabling targeted business strategy development.
    • Healthcare Provider Insights : Understand New Zealand's DHB procurement patterns, reimbursement frameworks, and clinical adoption rates to optimize product positioning and sales strategies in the local market.
    • Competitive Landscape Analysis : Identify key competitors, market share distribution, and competitive advantages specific to New Zealand's gastrointestinal stent sector for informed market entry or expansion planning.
    • Demographic & Clinical Trends : Access data on New Zealand's aging population demographics, disease prevalence patterns, and procedural volumes to forecast demand and align product development with local clinical needs.
    • Investment & Growth Opportunities : Identify high-potential segments, emerging applications, and partnership opportunities within New Zealand's healthcare system to maximize ROI and market penetration.

    Frequently asked questions

    What is the current size of the gastrointestinal stent market in New Zealand?

    New Zealand's gastrointestinal stent market is estimated at USD 2.47 million in 2026.

    What is the projected market size for gastrointestinal stents in New Zealand by 2031?

    New Zealand's gastrointestinal stent market is forecast to reach USD 3.17 million by 2031.

    What is the CAGR for the gastrointestinal stent market in New Zealand?

    New Zealand's gastrointestinal stent market is expected to grow at a CAGR of 5.1% from 2026 to 2031.

    What factors are driving growth in New Zealand's gastrointestinal stent market?

    New Zealand's market growth is driven by an aging population, increased prevalence of gastrointestinal disorders, improved healthcare reimbursement, and adoption of minimally invasive endoscopic procedures.

    Which stent types are most commonly used in New Zealand?

    New Zealand's market utilizes self-expanding metal stents (SEMS), plastic stents, and increasingly fully covered metal stents for esophageal, biliary, and colorectal applications.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories; databases such as Bloomberg Business, Factiva, and Dun & Bradstreet; white papers; annual reports; company house documents; investor presentations; and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the gastrointestinal stent market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the gastrointestinal stent market. Primary sources from the demand side include gastroenterologists, interventional endoscopists, and surgeons from hospitals and ambulatory surgical centers, as well as directors of endoscopy units and gastrointestinal clinics.

    A breakdown of the primary respondents is provided below:

    Gastrointestinal Stent Market Size, and Share

    Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

    Note 2: Other designations include sales, marketing, and product managers.

    Note 3: Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the gastrointestinal stent market was determined through data triangulation using three approaches, as outlined below. After each approach, the weighted average of the three approaches was calculated based on the level of assumptions used in each.

    Gastrointestinal Stent Market : Top-Down and Bottom-Up Approach

    Gastrointestinal Stent Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed where applicable to complete the overall market engineering process and derive the exact statistics for all segments and subsegments.

    Market Definition

    The gastrointestinal stent market comprises medical devices designed for the minimally invasive management of obstructions, strictures, leaks, and fistulas within the gastrointestinal tract, including the esophagus, stomach, intestines, and biliary system. These stents, primarily self-expanding metal, plastic, and biodegradable variants, are deployed endoscopically or fluoroscopically to restore luminal patency, enable fluid drainage, and support tissue healing in both malignant and benign conditions. The market includes products, delivery systems, and associated technologies used across hospitals, ambulatory surgical centers, and specialty clinics, with applications spanning oncology, post-surgical complications, and chronic gastrointestinal disorders, driven by the growing preference for minimally invasive treatment approaches and improved patient outcomes.

    Key Stakeholders

    • GI stent manufacturers (metal, plastic, biodegradable stents)
    • Endoscopy device & delivery system manufacturers
    • Raw material & component suppliers (metals, polymers, coatings)
    • Hospitals & ambulatory surgical centers (public & private)
    • Gastroenterology clinics & endoscopy centers
    • Gastroenterologists, interventional endoscopists & GI surgeons
    • Contract manufacturers & OEM partners
    • Distributors & regional channel partners
    • Academic & clinical research institutions
    • Regulatory authorities & healthcare agencies
    • Market research & consulting firms
    • Investors & private equity firms

    Report Objectives

    • To define, describe, segment, and forecast the gastrointestinal stent market by product, type, application, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall gastrointestinal stent market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the gastrointestinal stent market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the gastrointestinal stent market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Customization Options:

    With the market data provided, MarketsandMarkets offers customizations to meet your company’s specific needs. The following customization options are available for the report:

    Company Information

    • Detailed analysis and profiling of additional market players (up to 5)

    Geographic Analysis

    • Further breakdown of the Rest of Europe gastrointestinal stent market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin America gastrointestinal stent market into Colombia, Chile, and other countries

    Competitive Landscape Assessment

    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the gastrointestinal stent market
    • Competitive leadership mapping for established players in the US

    Get the Full Gastrointestinal Stent Market Report

    Full forecast, segment splits, and company analysis for all Gastrointestinal Stent Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status